Company Performance Metrics
- Sella Brosh: Founding member, CEO
- Ilai Schwartz: Co-Founder, CTO
NVision Imaging develops quantum-based medical imaging technology that enhances the capabilities of standard magnetic resonance imaging (MRI) systems. The company’s platform uses hyperpolarization technology to increase the visibility of natural metabolic agents during MRI scans, allowing clinicians and researchers to observe metabolic activity at
the cellular level. Its POLARIS system is designed for both preclinical and clinical applications, supporting earlier assessment of treatment response, particularly in cancer care. NVision Imaging also explores applications of metabolic MRI in cardiology, neurology, hepatology, nephrology, and rheumatology by enabling faster detection of physiological changes associated with disease and treatment. The company combines expertise in quantum physics, imaging technology, and medical research to develop tools that integrate with existing MRI infrastructure.